Pharmacokinetics of lorazepam in critically ill neonates with seizures.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1538303.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pharmacokinetic data were evaluated in 10 term neonates with seizures after intravenous administration of lorazepam, 0.05 mg/kg or 0.1 mg/kg. All seizure activity ceased, with no adverse effects. Pharmacokinetic data revealed a decreased volume of distribution and clearance, and a prolonged half-life in comparison with data from older children and adults. These findings are consistent with physiologic differences in the neonate.
Medical subject headings
- Infant, Newborn
- Lorazepam
- Seizures